Area of research
Pharmacology · Economics and Econometrics
Research interest
Research interests include Pharmaceutical industry and healthcare, Pharmaceutical Economics and Policy, Schizophrenia research and treatment, and Neurotransmitter Receptor Influence on Behavior.
Raising the bar for disclosure of industry payments to doctors
Direct-to-consumer advertising: a modifiable driver of overdiagnosis and overtreatment
Most high-income countries ban direct advertising of prescription drugs – why does NZ still allow it?
Time for New Zealand to ban direct-to-consumer advertising of prescription medicines
78 Direct-to-consumer advertising: a modifiable driver of overdiagnosis and overtreatment
The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression
Challenging the promotion of antidepressants for nonsevere depression
What Does ‘Unpaid Consultant’ Signify? A Survey of Euphemistic Language in Conflict of Interest Declarations
Skilled use of the media by vested interests to promote drugs and other health products
Marketing versus evidence-based medicine